This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5brz
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
==MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1== | ==MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1== | ||
| - | <StructureSection load='5brz' size='340' side='right' caption='[[5brz]], [[Resolution|resolution]] 2.62Å' scene=''> | + | <StructureSection load='5brz' size='340' side='right'caption='[[5brz]], [[Resolution|resolution]] 2.62Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5brz]] is a 5 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5BRZ OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[5brz]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5BRZ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5BRZ FirstGlance]. <br> |
| - | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.62Å</td></tr> |
| - | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5brz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5brz OCA], [https://pdbe.org/5brz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5brz RCSB], [https://www.ebi.ac.uk/pdbsum/5brz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5brz ProSAT]</span></td></tr> |
</table> | </table> | ||
| - | == Disease == | ||
| - | [[http://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Defects in B2M are the cause of hypercatabolic hypoproteinemia (HYCATHYP) [MIM:[http://omim.org/entry/241600 241600]]. Affected individuals show marked reduction in serum concentrations of immunoglobulin and albumin, probably due to rapid degradation.<ref>PMID:16549777</ref> Note=Beta-2-microglobulin may adopt the fibrillar configuration of amyloid in certain pathologic states. The capacity to assemble into amyloid fibrils is concentration dependent. Persistently high beta(2)-microglobulin serum levels lead to amyloidosis in patients on long-term hemodialysis.<ref>PMID:3532124</ref> <ref>PMID:1336137</ref> <ref>PMID:7554280</ref> <ref>PMID:4586824</ref> <ref>PMID:8084451</ref> <ref>PMID:12119416</ref> <ref>PMID:12796775</ref> <ref>PMID:16901902</ref> <ref>PMID:16491088</ref> <ref>PMID:17646174</ref> <ref>PMID:18835253</ref> <ref>PMID:18395224</ref> <ref>PMID:19284997</ref> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/MAGA3_HUMAN MAGA3_HUMAN] Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes.<ref>PMID:20864041</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 21: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5brz" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5brz" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Beta-2 microglobulin 3D structures|Beta-2 microglobulin 3D structures]] | ||
| + | *[[MHC 3D structures|MHC 3D structures]] | ||
| + | *[[MHC I 3D structures|MHC I 3D structures]] | ||
| + | *[[T-cell receptor 3D structures|T-cell receptor 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: Bossi | + | [[Category: Homo sapiens]] |
| - | [[Category: Cole | + | [[Category: Large Structures]] |
| - | [[Category: Donnellan | + | [[Category: Bossi G]] |
| - | [[Category: Dukes | + | [[Category: Cole DK]] |
| - | [[Category: Hassan | + | [[Category: Donnellan Z]] |
| - | [[Category: Hickman | + | [[Category: Dukes J]] |
| - | [[Category: Jakobsen | + | [[Category: Hassan N]] |
| - | [[Category: LeProvost | + | [[Category: Hickman E]] |
| - | [[Category: LomaX | + | [[Category: Jakobsen BK]] |
| - | [[Category: Mahon | + | [[Category: LeProvost G]] |
| - | [[Category: Oates | + | [[Category: LomaX M]] |
| - | [[Category: Raman | + | [[Category: Mahon T]] |
| - | [[Category: Rizkallah | + | [[Category: Oates J]] |
| - | [[Category: Sami | + | [[Category: Raman MCC]] |
| - | [[Category: Simmons | + | [[Category: Rizkallah PJ]] |
| - | [[Category: Vuidepot | + | [[Category: Sami M]] |
| - | + | [[Category: Simmons R]] | |
| - | + | [[Category: Vuidepot A]] | |
Current revision
MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1
| |||||||||||
Categories: Homo sapiens | Large Structures | Bossi G | Cole DK | Donnellan Z | Dukes J | Hassan N | Hickman E | Jakobsen BK | LeProvost G | LomaX M | Mahon T | Oates J | Raman MCC | Rizkallah PJ | Sami M | Simmons R | Vuidepot A
